Key Takeaways
- •A 2021 study in Nature Communications by Kim et al.
- •MOTS-c stands for Mitochondrial ORF of the 12S rRNA Type-C.
- •This peptide joins mitochondria-derived peptides (MDPs), a small group encoded by the mitochondrial genome rather than nuclear DNA.
MOTS-c: The Mitochondrial Peptide for Metabolic Health
A 2021 study in Nature Communications by Kim et al. revealed MOTS-c as an exercise-induced peptide that boosts physical performance in aged mice to levels seen in younger animals. This 16-amino-acid sequence, MRWQEMGYIFYPRKLR, comes from mitochondrial DNA and influences metabolic health. Scientists first described it in 2015 through work by Lee et al. at the University of Southern California.
Origins and Structure
MOTS-c stands for Mitochondrial ORF of the 12S rRNA Type-C. It resides within the 12S ribosomal RNA gene of the human mitochondrial genome. Changhan David Lee and colleagues at the USC Leonard Davis School of Gerontology identified and characterized it in 2015.
This peptide joins mitochondria-derived peptides (MDPs), a small group encoded by the mitochondrial genome rather than nuclear DNA. The mitochondrial genome holds just 37 genes: 13 proteins, 22 tRNAs, and 2 rRNAs. Such a source rarely yields signaling peptides, so MOTS-c expanded knowledge in this area.
Researchers detect MOTS-c in human plasma, skeletal muscle, and various tissues. Check the Peptide Glossary for details on related terms.
Mitochondria-to-Nucleus Signaling
MOTS-c enables retrograde communication, shifting from mitochondria to the nucleus during metabolic stress like glucose restriction, oxidative stress, or intense exercise. In the nucleus, it binds the antioxidant response element (ARE) and triggers the Nrf2 transcription pathway. Nrf2 controls genes for antioxidant defense, inflammation control, and metabolic shifts.
This process lets mitochondria detect stress and direct nuclear gene changes. A 2018 Cell Metabolism paper by Kim KH et al. detailed this translocation and regulation under stress.
AMPK Activation in Key Tissues
MOTS-c turns on AMPK, the main cellular energy sensor, in skeletal muscle and liver. AMPK responds to low ATP versus AMP ratios by promoting fat breakdown, glucose uptake, and blocking energy-consuming processes.
Preclinical models show these changes lead to higher glucose uptake, increased fatty acid oxidation, more mitochondrial biogenesis, and better insulin sensitivity. A 2015 Cell Metabolism study by Lee C et al. linked MOTS-c to metabolic balance, reduced obesity, and less insulin resistance.
Decline with Aging
Human studies report lower circulating MOTS-c in older adults versus younger ones. Rodent data confirm drops in skeletal muscle, liver, and plasma over time, indicating a body-wide effect.
This pattern ties to metabolic worsening in aging. Experts suggest declining MOTS-c contributes to these issues, not just marks them. Use the Half-Life Calculator to explore peptide dynamics in research contexts.
Exercise Mimetic Properties
The 2021 Nature Communications study by Reynolds JC et al. (also Kim et al.) found exercise raises MOTS-c in muscle and plasma of rodents and humans. In older mice given MOTS-c, grip strength and treadmill endurance improved markedly.
These findings highlight MOTS-c in exercise physiology, muscle maintenance, and fighting age-related weakness like sarcopenia. Follow latest peptide news for updates on such studies.
Links to Diabetes and Beta Cell Health
A 2025 Experimental & Molecular Medicine publication examined MOTS-c in pancreatic beta cell aging. Treatment of aged mouse islets cut senescence signs by altering nuclear genes and metabolites tied to beta cell decline.
Human data from that study showed much lower circulating MOTS-c in type 2 diabetes patients than in healthy people. This supports its role in blood sugar control and builds on prior links to diabetes.
Interest in Cognitive and Neurological Research
The Alzheimer's Drug Discovery Foundation lists MOTS-c as a focus for cognitive vitality research. Its actions on stress responses and metabolism draw attention from aging and brain degeneration scientists.
No human trials in neurology appear yet, but the profile sparks interest. A 2017 Journal of Physiology review by Kim SJ et al. covered MDPs as metabolism regulators.
In summary, MOTS-c research underscores its potential in metabolic regulation, aging, and exercise benefits through unique mitochondrial signaling. Declining levels with age point to roles in disease models. Ongoing studies continue to clarify its mechanisms.
Related Research Compounds
Looking for high-purity research peptides? Browse our catalog for HPLC-verified compounds.
| Compound | Purity | Size | Price |
|---|---|---|---|
| MOTS-C 20mg | ≥98% | 20mg | $54.00 |